tbuckley/cabot-search huggingface dataset:
Electronic Cigarette Use Among Populations of Women During Reproductive Years
Authors: Alain Braillon
Journal: JAMA Pediatrics (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Pediatrics HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Pediatrics journal
Genome-wide Analyses of Chromatin State in Human Mast Cells Reveal Molecular Drivers and Mediators of Allergic and Inflammatory Diseases
Authors: Gökhan Cildir, John Toubia, Kwok Ho Yip, Mingyan Zhou, Harshita Pant, Pravin Hissaria, Jingxian Zhang, Wanjin Hong, Nirmal Robinson, Michele A. Grimbaldeston, Angel F. Lopez, Vinay Tergaonkar
Journal: Immunity (2019)
P1.04-72 Tumor Mutational Burden as a Potential Predictive Biomarker of Response to PD-1/PD-L1 Blockade in Non-Small Cell Lung Cancer
Authors: H. Kim, H.J.K. Kwon, E.S.K. Kim, Y.B. Han, J. Lee, S.H. Kim, Y.J. Kim, J. Lee, J. Chung
Journal: Journal of Thoracic Oncology (2019)
MA08.10 Early and Late Outcomes After Surgery for pT4 NSCLC Reclassified by AJCC 8th Edition Criteria
Authors: J. Mouhanna, A. Katz, P. Fiset, R. Rayes, A. Siblini, E. Lee, A. Seely, C. Sirois, D. Mulder, J. Cools-Lartigue, L. Ferri, J. Spicer
Journal: Journal of Thoracic Oncology (2019)
The IKK Inhibitor PS1145 Allows to Overcome Imatinib Resistance.
Authors: Daniela Cilloni, Francesca Messa, Francesca Arruga, Ilaria Defilippi, Alessandro Morotti, Emanuela Messa, Sonia Carturan, Milena Fava, Enrico Gottardi, Giovanni Martinelli, Michele Baccarani, Giuseppe Saglio
Journal: Blood (2004)
The Association of Abdominal Adiposity With Mortality in Patients With Stage I–III Colorectal Cancer
Authors: Justin C Brown, Bette J Caan, Carla M Prado, Elizabeth M Cespedes Feliciano, Jingjie Xiao, Candyce H Kroenke, Jeffrey A Meyerhardt
Journal: JNCI Journal of the National Cancer Institute (2019)

The quantity and distribution of adipose tissue may be prognostic measures of mortality in colorectal cancer patients, and such associations may vary by patient sex.This cohort included 3262 stage I-III colorectal cancer patients. Visceral and subcutaneous adipose tissues were quantified using computed tomography. The primary endpoint was all-cause mortality. Restricted cubic splines estimated statistical associations with two-sided P values.Visceral adipose tissue was prognostic of mortality in a reverse L-shaped pattern (nonlinear P = .02); risk was flat to a threshold (∼260 cm2) then increased linearly. Subcutaneous adipose tissue was prognostic of mortality in a J-shaped pattern (nonlinear P < .001); risk was higher at extreme (<50 cm2) but lower at intermediate values (>50 to ≤560 cm2). Patient sex modified the prognostic associations between visceral adipose tissue (Pinteraction = .049) and subcutaneous adipose tissue (Pinteraction = .04) with mortality. Among men, visceral adiposity was associated with mortality in a J-shaped pattern (nonlinear P = .003), whereas among women, visceral adiposity was associated with mortality in a linear pattern (linear P = .008). Among men, subcutaneous adiposity was associated with mortality in an L-shaped pattern (nonlinear P = .01), whereas among women, subcutaneous adiposity was associated with mortality in a J-shaped pattern (nonlinear P < .001).Visceral and subcutaneous adipose tissue were prognostic of mortality in patients with colorectal cancer; the shape of these associations were often nonlinear and varied by patient sex. These results offer insight into the potential biological mechanisms that link obesity with clinical outcomes in patients with cancer, suggesting that the dysregulated deposition of excess adiposity is prognostic of mortality.
Illegal products containing THC are blamed for vaping lung disease in Utah
Authors: Janice Hopkins Tanne
Journal: BMJ (2019)

An outbreak of vaping related lung disease in the US state of Utah was related to the use of unregulated cartridges containing tetrahydrocannabinol (THC), researchers have reported.

Utah’s rate of vaping related lung disease was 26 per million, compared with four per million nationally, say the researchers from the Centers for Disease Control and Prevention (CDC), the Utah Department of Health, the University of Utah, and local Utah health departments in the Morbidity and Mortality Weekly Report .1

The Utah Department of Health has started a campaign to alert the public to the potential dangers of using THC vaping products.

It has also banned the …
P2.05-01 Broad Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer
Authors: V. Nair, A. Bik-Yu Hui, J. Chabon, M. Esfahani, H. Stehr, B. Nabet, J. Benson, A. Chaudhuri, L. Zhou, K. Ayers, H. Bedi, M. Ramsey, R. Van Wert, A. Sung, N. Lui, L. Backhus, M. Berry, P. Massion, J. Shrager, A. Alizadeh, M. Diehn
Journal: Journal of Thoracic Oncology (2019)
P1.01-60 Prognostic Impact of PD-L1 Expression on EGFR Tyrosine Kinase Inhibition in Lung Adenocarcinoma
Authors: M. Kang, S.H. Kim, S.W. Yoon, K.J. Suh, Y.J. Kim, C. Ock, M. Kim, B. Keam, T.M. Kim, D.S. Heo, J. Lee
Journal: Journal of Thoracic Oncology (2019)
OA06.01 Comparison Between Radiomics-Based Machine Learning and Deep Learning Image Classification for Sub-Cm Lung Nodules
Authors: I. Janzen, S. Seyyedi, R. Abraham, S. Atkar-Khattra, J. Mayo, R. Yuan, R. Myers, S. Lam, C. Macaulay
Journal: Journal of Thoracic Oncology (2019)
P1.01-87 Osimertinib Acquired Resistance Mechanisms and Post-Progression Outcomes in Stage IV EGFR Positive Non-Small Lung Cancer
Authors: T. Patil, A. Dimou, J. Pacheco, D. Smith, D. Aisner, D. Merrick, C. Rusthoven, B. Kavanaugh, R. Miller, E. Schenk, D.R. Camidge, P. Bunn, R. Doebele
Journal: Journal of Thoracic Oncology (2019)
P1.04-11 Depicting the Intra-Tumoral Viral and Microbial Landscape of Localized NSCLC Using Standard Next Generation Sequencing Data
Authors: P. Gaudreau, N. Ajami, B. Sepesi, T. Karpinets, A. Reuben, M. Wong, E. Parra, L. Federico, V. Gopalakrishnan, K. Mitchell, M. Negrao, C. Spencer, A. Vaporciyan, A. Weissferdt, C. Haymaker, H. Tran, C. Bernatchez, L. Landry, E. Roarty, T. Cascone, J. Heymach, J. Zhang, I. Wistuba, J. Zhang, J. Wargo, D. Gibbons
Journal: Journal of Thoracic Oncology (2019)
Efficacy of Radiation Treatement in Ocular Adnexa Mucosa-Associated Lymphoid Tissue Lymphoma: A Retrospective Evaluation in a Single Center Experience
Authors: Dario Marino, Maital Bolshinsky, Silvia Finotto, Raffaele Parrozzani, Caterina Boso, Federica Vianello, Edoardo Midena, Luca Canziani, Laura Evangelista, Vittorina Zagonel
Journal: Blood (2017)
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
Authors: Kristofer Andréasson, Dirk M Wuttge, Frank A Wollheim
Journal: New England Journal of Medicine (2019)

Although there were only 7 patients with FGFR2 fusion in our trial, none of whom had an objective response, we note that the disease control rate in this group was 71%, which is similar to that in the overall trial population.Having said that, more information is needed to understand the clinical benefit of erdafitinib both in patients with no history of chemotherapy and in those with FGFR alterations.
MA21.06 Preliminary Phase 1 Results of U3-1402 — A Novel HER3-Targeted Antibody–Drug Conjugate—in EGFR TKI-Resistant, EGFR-Mutant NSCLC
Authors: H. Yu, M. Johnson, C. Steuer, M. Vigliotti, S. Chen, Y. Kamai, C. Yu, P. Jänne
Journal: Journal of Thoracic Oncology (2019)
Highlights of ESC Congress 2019: a report from the ESC Scientists of Tomorrow
Authors: Mahmoud Abdellatif, Jyoti Patel, Anke M Smits
Journal: Cardiovascular Research (2019)

After a year full of successful meetings, including ESC 2018, 1 AHA 2018, 2 and ACC 2019 3 , delegates from all over the word now reconvened in Paris, for the ESC Congress 2019, organized jointly with the World Congress of Cardiology.Over 33 500 participants attended the 5-day conference that covered a variety of late-breaking science, the latest clinical trials, practical workshops, and career development events, with the highlight being on Global Cardiovascular Health, emphasizing the differences in prevalence, clinical manifestations, strategies, and management of cardiovascular diseases around the world.The sessions of Basic Science expanded to identify where the future of cardiology is going with new innovations towards personalized medicine.Sessions on 'Translating new pharmacology science into clinical practice' and 'Cardiac tissue engineering: disease modelling and novel therapeutics' highlighted the key role of translational medicine in this field and the need to fully understand the molecular and cellular background of underlying conditions to take science from bench to bedside.One of the new technologies that appeared to be omnipresent in the basic science area was single-cell sequencing.In a very well-attended session, it was shown that this technique is quickly expanding our knowledge on cellular compositions and molecular signatures in for instance cardiac development, atherosclerosis, and the infarcted heart, and it will provide new therapeutic approaches for cardiovascular disease.To celebrate her outstanding achievements in the field of inherited cardiac disorders, the ESC William Harvey Lecture on Basic Science lecture entitled: 'When genetic burden reaches threshold' was given by Prof. Connie Bezzina from the Amsterdam
EP1.05-06 Benefits of 18F-FDG PET/CT-Guided Core-Needle Biopsy in Necrotic or Recurrent Chest Tumors
Authors: V. Voitko, V. Sokolov, O. Voitko, Y. Kmetyuk, E. Oliinichenko, V. Getman
Journal: Journal of Thoracic Oncology (2019)
Validation of the OncoMasTR Risk Score in Estrogen Receptor–Positive/HER2-Negative Patients: A TransATAC study
Authors: Richard Buus, Ivana Sestak, Stephen Barron, Tony Loughman, Bozena Fender, Cesar Lopez Ruiz, Peter Dynoodt, Chan-Ju Angel Wang, Des O'Leary, William M. Gallagher, Mitch Dowsett, Jack Cuzick
Journal: Clinical Cancer Research (2019)

Abstract Purpose: To test the validity of OncoMasTR Molecular Score (OMm), OMclin1, and OncoMasTR Risk Score (OMclin2) prognostic scores for prediction of distant recurrence (DR) in estrogen receptor (ER)-positive/HER2-negative breast cancer treated with 5 years' endocrine therapy only and compare their performance with the Oncotype DX Recurrence Score (RS). Experimental Design: OMm incorporates three master transcription regulator genes. OMclin1 combines OMm, tumor size, grade, and nodal status; OMclin2 incorporates OMm, tumor size, and nodal status. OMclin1 and OMclin2 were evaluated for 646 postmenopausal patients with ER-positive/HER2-negative primary breast cancer with 0–3 involved lymph nodes in TransATAC. Patients were randomized to 5 years' anastrozole or tamoxifen without chemotherapy. RS was available in all cases. We used likelihood ratio-χ2, C-index, and Kaplan–Meier analyses to assess prognostic information. Results: OMm, OMclin1, and OMclin2 were highly prognostic for prediction of DR in years 0–10 among all patients [likelihood ratio (LR)-χ2 = 25.4, 48.7, and 45.0, respectively, all P &amp;lt; 0.001; C-index = 0.67, 0.71, and 0.71, respectively], compared with RS (LR-χ2 = 18.8; P &amp;lt; 0.001; C-index = 0.63). All three scores provided significant additional prognostic value beyond clinical treatment score, Nottingham Prognostic Index, and Ki67. OMclin1 and OMclin2 categorized 190 and 267 node-negative patients as low risk (DR rates: 2.9% and 4.9%, respectively). In comparison, RS categorized 296 node-negative patients as low-risk and 128 patients as intermediate-risk (DR rate: 6.6% and 17.3%, respectively). Conclusions: OMm, OMclin1, and OMclin2 were highly prognostic for early and late DR in women with early-stage ER-positive breast cancer receiving 5 years' endocrine therapy. In TransATAC, OMclin1 and the OncoMasTR Risk Score (OMclin2) were superior to RS in identifying patients at increased risk of DR.
Time to put down the scalpel? The role of surgery in tendinopathy
Authors: Neal L Millar, George A C Murrell, Paul Kirwan
Journal: British Journal of Sports Medicine (2019)

‘ Constant attention by a good nurse may be just as important as a major operation by a surgeon ’ goes the famous yet rarely used quote from the early 20th century and is something we should pause and consider for our tendon patients. We argue that there is often a ‘silo’ approach in the management of tendinopathy based on the practitioner who first encounters the tendinopathy patient. Surgeons tend to ignore loading regimes, physiotherapists can be dismissive of surgery even when the patient is not making progress and we contend that many sports doctors use ‘novel’ treatment modalities which have a little evidence base.

This divergent approach to management in daily practice among specialties merely highlights how difficult the decision-making process in tendinopathy is for the treating healthcare professional. In many practitioners’ minds, surgery has always been the last resort of failed responders to various non-medical management. While expert opinions, guidelines and systematic reviews have attempted to guide clinicians on when surgery may be an appropriate next treatment step, there is little evidence comparing surgical versus non-surgical treatments.1 

What does the literature …
Alterations in Mesenchymal Stromal Precursor Cells in Patients with Chronic Myeloid Leukemia at the Onset of the Disease and During Treatment By Tyrosine Kinase Inhibitors
Authors: Nataliya Petinati, Irina Shipounova, Alexey Bigildeev, Natalia Sats, Tamara Sorokina, Ekaterina Chelysheva, Oleg Shukhov, Anna Petrova, Anna G Turkina, Nina Drize
Journal: Blood (2017)
Potassium channel expression profiles in human melanoma cells.
Authors: Susanna Niedling, Kristina M. Schoenherr, Keith Hoek, Reinhard Dummer, Mirjana Ziemer, Martin Kaatz, Stefan H. Heinemann, Roland Schoenherr
Journal: Cancer Research (2006)

5024  Potassium channels are well known for their roles in electrical signaling and volume regulation. More recently, increasing evidence indicates an additional role for this protein family in tumor formation. Aberrant expression of individual potassium channel types is well described for several cancer types and pharmacological channel blockade was found to reduce cellular proliferation. However, expression analyses for potassium channels in cancer cells are largely restricted to a small number of individual genes out of a large potassium channel gene family. Using an electrophysiological approach, we previously identified calcium-activated KCNN4 channels (IK) and voltage-gated KCNH1 channels (EAG1) in human melanoma cell lines. Here we applied the Affymetrix whole genome arrays HG-U133A and HG-U133B to compare mRNA expression patterns in three individual melanocyte cultures versus twelve primary cell cultures derived from melanoma metastases. From a total of 80 potassium channel genes (KCN*) represented on these chips, only nine genes were differentially regulated (> 2-fold) in at least 9 of 12 melanoma cell lines; six were upregulated while three were downregulated. Interestingly, KCNN4 was the only potassium channel gene that was upregulated in all melanoma lines. The mean mRNA level for this gene in melanoma was 12-fold increased compared to melanocytes. mRNA for KCNH1 was not detected by the respective array probe set, while electrophysiological recordings as well as quantitative RT-PCR confirmed expression of this channel in several cell lines. Thus, a certain \. number of false negative results from the chip data must be considered. To further elucidate the role of KCNN4 channels in tumor cells we analyzed mRNA levels in freshly isolated tumor tissue from either primary melanoma or melanoma metastases by quantitative RT-PCR. 20 out of 23 analyzed tumor specimens were clearly positive for KCNN4 expression. Furthermore, patch-clamp recordings from freshly cultivated cells from selected melanoma specimens revealed the functional expression of typical calcium-activated KCNN4 channels with sensitivity to charybdotoxin and clotrimazole. In summary, our results define a set of potassium channels with aberrant expression in human melanoma that may provide new markers and potential therapeutic targets for human melanoma.
P1.14-15 Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey
Authors: S. Kilickap, U. Demirci, F. Bugdayci, D. Tural, T. Korkmaz, S. Paydas, C. Yilmaz, H. Turna, A. Sezer, H. Yesil Cinkir, K. Okutur, M. Erman, Y. Eralp, D. Cabuk, A. Isikdogan, A. Demirkazik, A. Karaoglu, D. Yazilitas, F. Cay Senler, P.F. Yumuk, H. Coskun, I. Yildiz, I. Oztop, I. Beypinar, K. Aydin, M. Kaplan, N. Meydan, O.F. Olmez, O. Ozyilkan, S. Seber, C. Arslan, M.A. Sendur, I. Cicin
Journal: Journal of Thoracic Oncology (2019)
P1.01-78 Treatment-Related Adverse Events in Patients with Advanced NSCLC Treated with First-Line Atezolizumab Chemoimmunotherapy
Authors: S. Swarup, K. Thein, A. Sultan, N. Jahan, M. Quirch, S. Meda, T. Htut, N. Adhikari, P. Hlaing, A. Dash, A. Tun, S. Rehman, F. Hardwicke, L. Tijani
Journal: Journal of Thoracic Oncology (2019)
Trends in Internet Searches for Cannabidiol (CBD) in the United States
Authors: Eric C. Leas, Alicia L. Nobles, Theodore L. Caputi, Mark Dredze, Davey M. Smith, John W. Ayers
Journal: JAMA Network Open (2019)

Cannabidiol (CBD) is widely promoted as a panacea. For example, the cannabis brand MedMen claims CBD treats acne, anxiety, opioid addiction, pain, and menstrual problems.1 However, the US Food and Drug Administration has only approved highly purified CBD (Epidiolex) for treating epilepsy. To our knowledge, there is currently no population-focused surveillance of public interest in CBD. Consequently, many question whether CBD should be prioritized by public health leaders and regulators. This article describes public interest in CBD within the United States.
A Study of Novel Beta Globin Mutation Associated with Dominant Beta-Thalassemia, Aberrant Erythroid Maturation and Differentiation Compounded with Hereditary Pyropoikilocytosis
Authors: Soo Jin Kim, Jihyun Song, John D. Phillips, Noel Scott Reading, Christine Min, Julio Lautersztain, Archana Agarwal, Josef T. Prchal
Journal: Blood (2017)
Intratumoral CD8 <sup>+</sup> T cells with stem cell–like properties: Implications for cancer immunotherapy
Authors: Werner Held, Imran Siddiqui, Karin Schaeuble, Daniel E. Speiser
Journal: Science Translational Medicine (2019)

Intratumoral PD-1 + TCF1 + CD8 + T cells with stem cell–like properties mediate cellular expansion and tumor control in response to immunotherapy.
EP1.09-13 Clinic-Pathological and Molecular Features of PD-L1 Analyses in Advanced NSCLC: A Real Life Single Center Experience
Authors: F. Tabbò, L. Righi, G. Rota, S. Cappia, A. Rigutto, S. Izzo, S. Novello, M. Volante
Journal: Journal of Thoracic Oncology (2019)
Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth
Authors: Liang-qi Cao, Xue-wei Yang, Yu-bin Chen, Da-wei Zhang, Xiao-Feng Jiang, Ping Xue
Journal: Molecular Cancer (2019)

Abstract Background As an important means of communication, exosomes play an important role in the development of hepatocellular carcinoma (HCC). Methods Bioinformatics analysis, dual-luciferase reporter assays, methylation-specific quantitative PCR, and ChIP-PCR analysis were used to gain insight into the underlying mechanism of miR-21 in HCC. Results The detection of miRNAs in exosomes of HCC showed that miR-21 expression in exosomes was positively correlated with the expression level of miR-21 in cells and negatively correlated with the expression of its target genes PTEN, PTENp1 and TETs. HCC cell-derived exosomes could increase miR-21 and p-Akt expression in HCC cells and downregulate the expression of PTEN, PTENp1 and TETs. MiR-21 inhibitors or PTENp1 overexpression vectors could weaken the effect of the abovementioned exosomes and simultaneously weaken their role in promoting cell proliferation and migration and inhibiting apoptosis. Further studies showed that miR-21 not only directly regulated the expression of PTEN, PTENp1 and TETs but also increased the methylation level of the PTENp1 promoter by regulating the expression of TETs, thereby inhibiting the expression of PTENp1 and further downregulating the expression of PTEN. Conclusions Exosomal miR-21 can regulate the expression of the tumor suppressor genes PTEN and PTENp1 in various ways and affect the growth of HCC cells.
P2.04-18 Analysis of Patient Microbiome and Its Correlation to Immunotherapy Response and Toxicity in Lung Cancer
Authors: J. Chau, M. Yadav, M. Furqan, N. Cady, K. Mercer, E. Eastman, T. Abu-Hejleh, G. Clamon, S. Shahi, Q. Dai, Y. Zakharia, R. Garje, C. Chan, G. Weiner, A. Mangalam, J. Zhang
Journal: Journal of Thoracic Oncology (2019)
EP1.01-30 Clinico-Pathological Profile of Adenocarcinoma of the Lung – A Prospective Study in a Nepalese Population
Authors: S. Dulal, B. Paudel, A. Shah, P. Neupane, B. Acharya, S. Chapagain, A. Rayamajhi, R. Thapa, O.T. Brustugun, N. Leighl
Journal: Journal of Thoracic Oncology (2019)
MA05.06 Feasibility and Safety of Transarterial Chemoperfusion for Advanced Pleural Mesothelioma: Interim Results of a Phase 2 Study
Authors: B. Creelan, M. Pereira, J. Logeman, B. Morse, D. Jeong, G. El-Haddad, J. Choi, J. Fontaine, T. Tanvetyanon, B. Kis
Journal: Journal of Thoracic Oncology (2019)
EP1.01-74 Implantation of Permanent Pleural Catheter (PPC) for Malignant Pleural Effusion (PE) in Advanced Non Small Cell Lung Cancer (NSCLC)
Authors: M. Martinez-Kareaga, I. Intxaurbe-Etxebarria, B. Mareque, N. Torrego, L. Tomás-López, C. Sánchez-Vieco, A. Narro, L. Puntí, G. García-Gómez, N. Urbieta
Journal: Journal of Thoracic Oncology (2019)
Efficacy of Extracorporeal Photopheresis (ECP) Monotherapy in the Treatment of Cutaneous T Cell Lymphoma.
Authors: Larisa Geskin, Francine Foss, Madeleine Duvic, David Straus, Steven Horwitz, Jasmine Zain, Timothy Kuzel, Christiane Querfeld, Kim Campbell, Robert Knobler
Journal: Blood (2007)
HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype
Authors: Rajeev Malhotra, Andreas C. Mauer, Christian L. Lino Cardenas, Xiuqing Guo, Jie Yao, Xiaoling Zhang, Florian Wunderer, Albert V. Smith, Quenna Wong, Sonali Pechlivanis, Shih-Jen Hwang, Judy Wang, Lingyi Lu, Christopher J. Nicholson, Georgia Shelton, Mary D. Buswell, Hanna J. Barnes, Haakon H. Sigurslid, Charles Slocum, Caitlin O’ Rourke, David K. Rhee, Aranya Bagchi, Sagar U. Nigwekar, Emmanuel S. Buys, Catherine Y. Campbell, Tamara Harris, Matthew Budoff, Michael H. Criqui, Jerome I. Rotter, Andrew D. Johnson, Ci Song, Nora Franceschini, Stephanie Debette, Udo Hoffmann, Hagen Kälsch, Markus M. Nöthen, Sigurdur Sigurdsson, Barry I. Freedman, Donald W. Bowden, Karl-Heinz Jöckel, Susanne Moebus, Raimund Erbel, Mary F. Feitosa, Vilmundur Gudnason, George Thanassoulis, Warren M. Zapol, Mark E. Lindsay, Donald B. Bloch, Wendy S. Post, Christopher J. O’Donnell
Journal: Nature Genetics (2019)